Theranos Inc. pledged to stay out of the blood-testing business for at least two years in exchange for reduced penalties from federal health authorities, the company said, in an agreement that resolves a year-long regulatory impasse.
from WSJ.com: US Business http://ift.tt/2nXl534
via IFTTT
No comments:
Post a Comment